Primary Care: Clinics in Office Practice 2000: Vol 27 Index

29 Pages·2000·6 MB·English

CUMULATIVE INDEX 2000
Volume 27
March UPDATE ON MATERNITY CARE, pages 1-276
June DERMATOLOGY, pages 277-523
September CARDIOVASCULAR DISEASE, pages 525-811
December OCCUPATIONAL AND ENVIRONMENTAL M
pages 813-1130
Page numbers of article titles are in boldface type
\bortion, spontaneous, in occupational ex- systemic agents for
posures, 1040, 1043 topical agents fo1
in shiftwork, 1064-1065 Acne fulminans, tre
in teratogen exposure, 6 Acquired immunod
\brasions, treatment of, 478-480 pregnancy
\bscess, skin, 465-466 Acrochordons, 280
\buse, domestic, prenatal screening for Acrodermatitis, papul
16-60 (Gianotti-Crost
Acanthosis nigricans, in diabetes mellitus 368
378-379 Acrylamide, occupationa
Accessory atrioventricular pathway, 689- O72 3-995
690 Acrylonitrile, occupatio1
Acebutolol, in angina, 624-625 925-927
Acetic acid, in external otitis, 469 Actinic keratosis, 43
\cetretin, in psoriasis, 404 histology of, 440-4
Acids, occupational exposure to, 917-921 treatment of, 440
\clometasone, in psoriasis, 393, 398 Acupuncture and acupr
Acne, 289-308 care, 118-119
classification of, 290 Acute respiratory dist
comedonal, 290-291, 303-305 toxic inhalation
definition of, 289 Acyclovir, in genital herpes
inflammatory, 291-292, 304 Adapalene gel, in acne
pathophysiology of, 289-290 Adenosine, in atrial arrhy
patient education on, 306-307 9
scars in, 291, 305 in coronary artery dis
severe, 292, 304-305 Adhesives, tissue, in lacer
treatment of, 292-30 / 478
adjunctive, 305-3( / Adrenal gland, tumors of
comedonal, 303-305 593
costs of, 307 Adrenergic stimulation
goals of, 292-293 Age, maternal, in pregna
inflammatory, 304 ment, 76
intralesional, 305 Agent Orange, dioxins i! upational ex
severe, 304—305 pI osure to, 951-95
1103
1104 CUMULATIVE INDEX 2000
AIDS. See Human immunodeficiency virus in American Academy ooff 1 P e¢
fection. screening recomme!
Albuminuria, in hypertension, 597 55°
Alcohol use, coronary artery disease and, American College of Obstetr
532, 744 COlOgy pia screenll
in pregnancy, 107 tions of, 557
screening for, 3-4, 77-78 rican Heart Associ
lipid effects of, 576 mmendation
Aldosterone, excess of, hypertension in,
592-593
Alkalis, occupational exposure to, 921-923 2
Allergic rhinitis, in pregnancy and lacta- p-Aminophen«
tion, drugs for, 46 927 —'
occupational, 999-1002 Amiodarone
Allergy, food, with atopic dermatitis, 504 697
Alopecia, androgenic, 323-326 Amitriptylin
classification of, 321-322 Amlodipin«
evaluation of, 322-323 Ammonia
nonscarring, 32 3-3303 970
scarring, 330-333 1 Amniocentesi
traction, 330 Amniotic
Alopecia areata, 327-329 lactation
Alopecia totalis, 327-328 Amphotericin B
Alpha blockers, in hypertension, 601 Ampicillin I
lipid effects of, 576 Amyl nitrite
Alpha fetoprotein test, in pregnancy, 88 in hydro
Alternative medicine, in maternity care, Anacardiaceat
117-136 See Riis dermatiti
acupuncture, 118-119, 124-125, 128 Analgesia, for burns, 485
aromatherapy, 121, 130 Androgeni Ca oper la 2
Chinese medicine, 118-119, 127-128 Anemia, in lead poisoning
chiropractic, 122-123, 125 Anesthetics, for abrasion t
comfort measures in, 129-131 in pregnancy <
doula care, 131 occupational exposur¢
for backache, 125-126 reproducti' ve disorders in
for breech presentation version, 127 Angina, 615-629
128 angina equivale] nts in
for childbirth preparation, 125 atypical, 618, 632-633
for labor induction, 128-129 classiffiiccaattiioonn of, + 626: 0)
for lactation, 131-132 clinical features of, 617
for nausea and vomiting, 124 definition of, 615
for pain relief, 129-131 diagnosis of, 619-62
for premature labor, 128 differential diagnosis of
herbal remedies, 119-121, 124, 129, diseases \
31-132 In aortic s
homeopathy, 121-122, 124, 128-130 in women, 747
hydrotherapy, 130 pathophysiology of, 616
hypnosis, 127-128 prevention of, 62
incorporation of, 132-133 Prinzmetal’s, 618
manipulative, 122-123 prognosis for, 62
>
massage, 122 sexuality and, 6
osteopathic, 122-123 treatment of, ¢ 1i 62
postpartum, 131 after myocardial infarction
spiritual healing, 123 variant, 618
types of, 118 versus silent ischemia, 628
17
in pregnancy and lactation, 51-52 Angiography, coronary, in ingina, O1/
American Academy of Family Physicians, in heart disease, 794
lipid screening recommendations of, in hypertension, 598-599
557-558 Angioplasty, coronary, in women
\ngiosarcoma, of liver, in vinyl chloride Asbestosis
exposure, 956-957 Asphyxiants, occupati
\ngiotensin-converting enzyme inhibitors chemical, 959
in heart failure, 664-665 npih ysical, 955 8
in hypertension, 602, 757-758
in renography, 598
in myocardial infarction, 644 in coronary arte
\ngiotensin II receptor antagonists, in 536
heart failure, 666 in myocardial infar
ular cheilitis, in diabetes mellitus, 374 Asthma in pregnat
\niline, occupational exposure to, 927 tor, 46
999 occupational
\nthracene, occupational exposure to shiftwork effec
9 47 —949 tenolol, in angina
\nthralins, in alopecia areata, 329 in silent myocardial is
in psoriasis, 397 Atherosclerosis, of cor
Antibiotics, in acne, 297-299 gina in. See
in blistering distal dactylitis, 466 pathopI hysiology ot
in cellulitis, 463 hyperlipidemia in
in erysipelas, 461 Athletes, screenin
in pregnancy, 14 yg ry 15 ,
in rosacea, 315 Athlete’s foot (tine
in staphylococcal scalded skin syndrome 418
467 Atopic dermatitis, 503-513
in sycosis barbae, 465 clinical course of, 504-505
srophylactic, in aortic stenosis, 729-7 clinical features of, 50¢
in mitral stenosis, 735 diagnosiso f, 505—50¢
A\nnt ticoagulants, in atrial fibrillation differential diagnosis
706
n pregnancy and lactation, 45—46
\ntidepressants, in atopic dermatitis, treatment of
Antihistamines, in atopic dermatitis, 5 Atorvastatin, in corona
in contact urticaria, Y06—90; prevention, 535
dermatitis, 499 in hyperlipidemia, 572
Antihypertensive drugs. See Hypertensior Atrial arrhythmias, 677-7
treatment of atrial fibrillation, 697
\ntioxidants, in angina, 626-627 atrial flutter, 692-693
in hyperlipidemia, 568 automatic atrial tachy
\ntiplatelet drugs, in coronary artery dis clinical features of,I ¢
ease prevention, 536 evaluation of, 677
\ntiretroviral therapy, for HIV infection, in irregular beats, 682
pregnancy, 22 multifocal atrial ta
Aortic arch defects, 769, 772 nonsinus atrial rhythm
\ortic valve, regurgitation of premature atrial comp!
stenosis of, 727—730 reentrant supray en
\polipoprotein B, defects of, 542 687-689
Aromatherapy, in maternity care, 121, 130 sick sinus syndrome
\romatic amines, occupational exposure sinoatrial block, 684
to, 927-929 sinus arrest, 684-685
Arrhythmias, cardiac. See Cardiac arrhyth sinus arrhythmia, 682
mias sinus bradycardia, 68
\rsenic, exposure to, 885, 991-993 sinus pause, 683
\rsine, occupational exposure to, 973-974 sinus rhythms, 679
Arthritis, in psoriasis, 341 sinus tachycardia, 68
Asbestos exposure, diseases related to, 888 supraventricular tach
isbestosis, 1028-1029 78-779
cancer, 1035-1036 wandering atrial pacen ixer
in health care workers, 1094—1095 Wolff-Parkinson-Whit
mesothelioma, 1033-1034 690
1106 CUMULATIVE INDEX 2000
Atrial fibrillation, 697-706 Baldness. See Alopecia
acute, 698 Basal cell carcinoma. See (
chronic, 698 Beau’s lines, 348-349
clinical features of, 698 Benzamycin, in acne, 298
electrocardiography in, 699 Benzidine, occupational exposure to, 927-
epidemiology of, 698 929
in women, 754 Benzo(a)pyrene occupational exposure to
pathophysiology of, 698-699 947 949
stroke risk in, 705-706 Benzoyl peroxide, in acne, 294
treatment of, antiarrhythmic drugs in, Beryllium, occupational exposure to, 1024-
702-704 1025
electrical cardioversion in, 701-702 Beta-blockers, in angina, 624-625
surgical, 704 in atrial fibrillation, 700
ventricular rate control in, 699-701 in heart failure, 666-668
Atrial flutter, 692-693 in hypertension, 600-601, 757
Atrial septal defects, 771, 777-778 in myocardial infarction, 643—644
Atrial tachycardia, 690-691 lipid effects of, 576
Atrophy, definition of, 284 Betamethasone, in psoriasis, 398
Atropine, in atrial arrhythmias, 694
in Rhus dermatitis, 500
Austin-Flint murmur, in aortic regurgita- ,
Bicipital tendonitis, work-related, 853-854
tion, 731
Biophysical profile, in fetal assessment, 96
Automatic atrial tachycardia, 690-691
Biopsy, nail, 338
Automaticity, defects of, arrhythmias in,
skin, in actinic keratosis, 441
710-711
in cancer, 453-454
Azathioprine, in atopic dermatitis, 512
Bipolar disorder, in pregnancy and lacta-
Azelaic acid, in acne, 296-297
tion, drugs for, 50
Birth defects, in occupational exposures
1040, 1043
Back pain, alternative medicine for, 125-126 maternal, evaluation of, 75
work-related, 865-875 Bisoprolol, in heart failure, 667
assessment of, 867-870 Bitumens, occupational exposure to, 947-
differential diagnosis of, 870 949
epidemiology of, 865 Black damp, occupational exposure to,
pathobiology of, 866 Q5R—050
prevention of, 872-873 Blackheads (comedones), 285, 290-291,
prognosis for, 871-872 303-305
risk factors for, 866-867 Bladder, infection of, in pregnancy, 17-18
treatment of, 870-872 Bleeding, vaginal, in pregnancy, 137-151
Bacterial infections, of skin, 459-473 Bleomycin, in warts, 431
blistering distal dactylitis, 466 Blisters, 466, 480—482
carbuncles, 465-466 Blood pressure, high. See Hypertension
cellulitis. See Cellulitis. measurement of, 591, 596
ecthyma gangrenosum, 470-471 Boils, 465-466
erysipelas, 460-462 Bradycardias, sinus, 680-681
erysipeloid, 466
Breast-feeding, alternative medicine in,
external otitis, 469-470
131-132
folliculitis. See Folliculitis.
drug use in. See Drug(s), in pregnancy and
furuncles, 465-466
lactation
impetigo, 459-460
Pseudomonas aeruginosa, 467-471 occupational exposures affecting, 1044
staphylococcal scalded skin syndrome, Breech presentation version, alternative
365-336686, ,46 7 medicine for, 127-128
toe web, 470 Bronchitis, chronic, occupational, 1030-
Bacterial vaginosis, in pregnancy, drugs 1032
for, 44 Bronchoprovocation tests, in occupational
prenatal screening for, 61, 63 lung diseases, 1013
Bacteriuria, in pregnancy, asymptomatic, Bruce protocol, for exercise testing, in an-
14-15 gina, 618
drugs for, 44 Bruits, in angina, 618
Bullae, 283, 377 incidence of, 448
Bullous impetigo, 459-460 metastasis from
Burns, 482-487 morbidity and mo
acid, 920-921 physical examina
alkali, 921-923 squamous cell ca
blisters in, 482 453
ethylene oxide, 932-933 treatment of, 454
extent of, 483 occupational, 909—‘
referral in, 483 andidiasis, cutaneous
sun, 435, 439 in diabetes mellitus
treatment of, 483-487 in pregnancy, 30-31
types of, 483-484 drugs for, 44
Burrow, definition of, 285 treatment of, 419
R, irsitis, subdeltoid, work-related, 853 antharidin, in warts
aplan’s syndrome
aptopril, in heart fai
in hypertension, 757
admium, occupational exposure to, 993 arbon black, occupation
994 947-949
aesarean section, in genital herpes, 27, 94 arbon dioxide, occuf
in plac enta previa, 140-141 958~—959
\GE questions, for substance abuse arbon dioxide digital sut
3 che
screening, prenatal, 4, 78-79 raphy, in hypertension, 598
alamine lotion, in Rhus dermatitis, 499 arbon disulfide, occupational exposure to,
alcipotriene, in psoriasis, 399 929-93]
alcium channel blockers, in angina, 625 arbon monoxide, occupational exposure
in aortic regurgitation, 731 to, 959-963
in hypertension, 601 arbuncles, 465-466
iulcium gluconate, in hydrofluoric acid ex arcinomas, skin. See C kin
sosure, 920-92 nae
pee ardiac arrest, in myocardial infarction
Calcium oxide, occupational exposure to, 63a ry
Q9 l -~923
; ardiac arrhythmias
alcium supplementation, in pregnancy,
rhythmias
106
; , ; diagnosis of, 797-799
anadian Task Force, lipid screening rec- =
vedincungaance? in myocardial infarction
ommendationso f, 557-579
ieee : ; . : in pediatric patients, 77
ancer, in occupational exposures, acrylo- gare
nitrile, 926-927 in women, 754-755
aromatic amine, 928-929 pathophy siology "
arsenic, 992~—993 triggered, 711-3 12
dioxin, 954 ventricular. See Vent
ethylene oxide, 933 Cardiogenic shock, in 1
formaldehyde, 935-936 tion, 637-638
lung, 1034-1036 ardiology, angina. Sec
nitrosamine, 940-941 atherosclerosis, 543-544
periconceptual, 1044 coronary artery disease
polychlorinated biphenyl, 945-946 tery disease , ’
polycyclic aromatic hydrocarbon, 948- diagnostic testing in, 78 -802. See also
949 specific techniques and diseases
skin, 909-910 for children. See Pediatr
styrene, 951 for women. See Wi
upper respiratory tract, 1006-1007 heart failure. See Heart fa
vinyl chloride, 956-957 hyperlipidemia. See Hyp
skin, from indoor tanning, 438 hypertension. See Hyp
melanoma, 438 myocardial infarctitlo n. See
nonmelanoma, 447-458 farction
basal cell carcinoma, 449, 452 valvular disease. See
biopsy of, 453-454 ease
follow-up, 457 ardiomegaly, in heart failure, 658
1108 CUMULATIVE INDEX 2000
Cardiomyopathy, dilated, 775 formaldehyde, 934-936
heart failure in, 656 hy drog 1 cyanide, 963
hypertrophic, 768 hyd rogen sulfide, 966-967
sudden death in, screening for, 712- in health ire workers, 1092
713, 778 in risk assessment, in pregnancy
mitochondrial, 768 76
peripartum, 781-782 irritant gases, 967-9
Cardiovascular disorders, in pregnancy nitrogen dioxide, 970-9
and lactation, drugs for, 45-46 nitroglycerin, 936-939
in shiftwork, 1062-1064 nitrosamines, 939-941
occupational, in nitroglycerin exposure, ozone, 972
937-939 pentachlorophenol, 941-944
Cardioversion, electrical, in atrial fibrilla- phosgene O69
tion, 701-702 physical asphyxiants, 958-959
Carpal tunnel syndrome, work-related, polychlorinated biphenyls, 944-946
858-859 polycy¢ lic aromatic hydrocarbons
Carvedilol, in angina, 624-625 946 i?) 49
in heart failure, 667-668 polyvinyl chloride, 955-957
CATCH-22 syndrome, 769 reproductive disorders in
Caustic potash, occupational exposure to, 1048
921-923 styrene, 949-95]
Caustic soda, occupational exposure to, sulfur dioxide, 972-973
921-923 vinyl chloride monomer, 955-95
Ceftriaxone, in gonorrhea, in pregnancy, 17 Chemother py drugs, occ upatic nal expo-
in pyelonephritis, in pregnancy, 16-17 sure to, 1093
Cellulitis, 460-464 Chest pain. See also Angin
alopecia in, 331 centers for, 641—642
around eye, 462-463 differential diagnosis of, 632-634
of extremities, 462 noncardiac, 633
of face, 462 recurrent, in myocardial infarction, 638-
perianal, 463-464 639
Pseudomonas aeruginosa, 468—469 troponin measurement in, 795-796
Cephalexin, in bacteriuria, in pregnancy, 15 Chest radiography, in heart failure, 659
Cephalosporins, in cellulitis, 463 in occupational lung diseases, 1011-1012
Cerebrovascular disease, in hypertension, Chicken skin, in atopic dermatitis, 506-507
609-610 Chickenpox. See Varicella
Cerivastatin, in coronary artery disease Chinese medicine, in maternity care 118-
prevention, 535 119, 127-128
in hyperlipidemia, 572, 57 Chiropractic medicine, in maternity care
Cesarean section, vaginal delivery after, 94 122 -123, 125
Cheilitis, angular, in diabetes mellitus, 374 Chlamydia trachomatis infections, in preg
Chelation therapy, for lead poisoning, 986 nancy, 31
Chemical peels, in actinic keratosis, 440- Chlamydial infections, in pregnancy and
441, 443 lactation, drugs for, 41-42
Chemicals. See also specific agents. Chloracne, in dioxin exposure, 953
occupational exposure to, 885-886, 917- in pentachlorophenol exposure, 943
982 in polychlorinated biphenyl exposure
acids, 917-921 945-946
acrylamide, 923-925 Chlorine, occupational exposure to, 967-
acrylonitrile, 925-927 968
alkalis, 921-923 Chlorpropamide, skin disorders due to, 381
ammonia, 969-970 Cholesterol. See also Hyperlipiden
aromatic amines, 927-929 dietary, 565-567
arsine, 973-974 lowering of, in coronary artery disease
carbon disulfide, 929-931 prevention, 534-53 5
carbon monoxide, 959-963 measurement of, 548-552
chlorine, 967-968 Cholestin, in hyperlipidemia, 571, 573-574
dioxins, 951-955 Cholestyramine, in coronary artery disease
ethylene glycol dinitrate, 936-939 prevention, 535, 553-554
ethylene oxide, 931-933 in hyperlipidemia, 573-574
horionic villus sampling, 95 atypical, 751
hromic acid, occupational exposure to diagnosis of, 790-—79¢
918-921 in women, 747
nasal perforation in, 1004 economic impact of
hromium, occupational exposure to, 994 epidemiology of, 5
imetidine, in warts, 432 ethnic factors in
ircadian rhythms, shiftwork and, 1057- family history of
1059 gender differences ir
lindamycin, in acne, 297-298 741-754
in streptococcal infections, 20 heart failure in, 656
lobetasol, in psoriasis, 398 in alcohol use, 53 2) > FAA
lofibrate, in hyperlipidemia, 573-574 in diabetes mellitus
lonidine, in hypertension, 602-603 1 elderly persons, 57
lotrimazole, in tinea pedis, 417 in estrogen deficien«
oal tar products, occupational exposure 745-746
to, 947-949 in exercise lack, 531
oal worker’s pneumoconiosis, 1029-1030 in homocysteinemia
olestipol, in coronary artery disease pre- in hyperlipidemia, 528
vention, 535 epidemiology of, 54
in hyperlipidemia, 573-574 pathophysiology
olitis, ulcerative, in pregnancy and lacta- prediction of
tion, drugs for, 47—48 prevention of
olor, of nails, 336-338 also Hyperlipider
of skin, 279 screening for
ymmedones, 285, 290-291 in hypertension
treatment of, 303-305 in women, 746
omplementary medicine. See Alternative in obesity, 530
medicine pediatric patients
omputed tomography, in hypertension, n shiftwork, 1063-1
598 stress, 532
in occupational lung diseases, 1012 n tobacco use, 5 ~ Q
onception, maternity care and. See Peri- in women, 526- 5
conception care mortality in é
ondyloma acuminatum, in pregnancy, myocardial infarction
27-28 infarction
onfidentiality, in occupational medicine, pathophysiology of
821-822 543-544
onfinement date, calculation of, 74 personality traits in, 532
ongenital heart disease, 769-772 prediction of, hyperlipidemia
ongestive heart failure. See Heart failure 552
onjunctivitis, in rubeola, 355 prevention of, 5
onstipation, in pregnancy and lactation hyperlipidemia a1
drugs for, 49 See also Hyperli}
onsultants, in occupational medicine, in women, 753-75
819-820 nonpharmacolo
ontact dermatitis, occupational, 896-903 pharmacologic
Rhus. See Rhus dermatitis risk factors for
ontact urticaria, occupational, 903-906 in women, 742-74
ontraceptives, oral, heart disease and, 758 sudden death risk in
in acne, 303 715
oronary artery(ies), angiography of, in an- treatment of, In wome!
gina, 617 orticosteroids, in atopic
in heart disease, 794 in lichen planus 3
angioplasty of, in women, 752 in psoriasis, 402
revascularization of, 637 of nails, 341-342
oronary artery bypass surgery, in women, of scalp, 391-392
752-753 systemic, 402-403
oronary artery disease, 525-540 topical, 398-399
angina in. See Angina in Rhus dermatitis, 499-50
1110 CUMULATIVE INDEX 2000
Corticosteroids (continued ) in shiftwork 1068-1069
intralesional, in acne, 305 postpartum prenatal screening for
lipid effects of, 576 60-62
Cough, angiotensin-converting enzyme in- prenatal screening for, 60-62
hibitor-induced, 665 DeQuervain’s disease, work-related 856
Crackles, in heart failure, 658 Dermatitis, atopic, 503-513
Creatinine kinase, measurement of, in myo- contact, occupational, 896-903
cardial infarction, 794-795 Rhus, 493-502
Creosote, occupational exposure to, 947— Dermatographism white, in atopic derma-
949 titis 09
Creutzfeld-Jakob disease, transmission of, Dermatology. See also Skin
to health care workers, 1086 hair disorders, 319-332
Crohn’s disease, in pregnancy and lacta- nail disorders, 333-351
tion, drugs for, 48 occupational. See Skin dis
Crust, definition of, 283 tional
Cryotherapy, for actinic keratosis, 443-444 terminology of, 277-287
for myxoid cysts, of nails, 348 Dermatophytid reaction, in tinea pedis, 412
for skin cancer, 455-456 Dermatophytosis, 408-412
for warts, 430-431 clinical types of, 409-413
Culture, fungal, 409 diagnosis of, 408-409
Curettage, of skin cancer, 455 of nails, 344-347
of warts, 431 of scalp, 330
Cyanide, occupational exposure to, 963- organisms causing, 408
966 treatment of, 417-418
Cyanoacrylates, in laceration repair, 475- Dermatoses, in diabetes mellitus, perforat-
478 ing, 379-380
Cyclosporine, in atopic dermatitis, 512 pigmented purpuric
in psoriasis, 404-405 Dermopathy, diabetic, 373
Cyst(s), acne, 291-292 Desonide, in psoriasis, 398
definition of, 285 Desoximethasone, in psoriasis, 398
myxoid, of nails, 347-348 Diabetes mellitus, coronary artery disease
Cystitis, in pregnancy, 17-18 in, 530, 746
Cytokines, in Rhus dermatitis, 497 cutaneous manifestations of, 371-383
Cytomegalovirus infections, in pregnancy, acanthosis nigricans, 378-379
25-26, 87, 108-109 bullae, 3
prevention of, in periconceptional care, 7 classification of, 372-373
~
transmission of, to health care workers, dermopathy, 373
1085-1086 epidemiologyo f, 371-372
eruptive xanthomas, 380-381
granuloma annulare, 377-378
infections, 372-375
Dactylitis, blistering, 466 lichen planus, 380
Dandruff, in psoriasis, 391-392 malignant external otitis, 470
Death, sudden, in arrhythmias, in women, necrobiosis lipoidica, 376-377
IO pathogenesis of, 371-372
in athletes, screening for, 712-715, 778 perforating dermatoses, 379-380
Débridement, of nail, in psoriasis, 342 rubeosis faciei, 375-376
Defibrillators, after myocardial infarction, thick skin, 375
645 F treatment-related, 373 381
atrial, 704 vitiligo, 380
Defoliants, dioxins in, occupational expo- yellow skin, 376
sure to, 951-955 gestational, prevention of, 5
Delivery. See Labor and delivery. hypertension in, 603
Dennie-Morgan lines, in atopic dermatitis, in pregnancy and lactation, drugs for, 49
508 prenatal screening for, 65-67
Depression, in myocardial infarction, 640- shiftwork effects on, 1066-1067
. : F /
641 Diagnostic testing, in heart disease, 785-
in pregnancy and lactation, drugs for, 802. See also specific techniques and
50-51 diseases
1111
algorithm for, 799 Food and Drug Administration catego-
interpretation of, 785-789 ries for, 37-39
Diarrhea, in pregnancy and lactation, drugs for cardiovascular disorders, 45-46
for, 49 for endocrine disorders, 49
infectious, transmission of, to health care for gastrointestinal lisorders, 47-49
workers, 1092 for infectious diseases, 39-45
Diet, as shiftwork countermeasure, 1070 for neurologic disord
for coronary artery disease prevention, for psychiatric dis
533, 560-569, 743-744 for pulmonary di
for heart failure, 670 for skin diseases
for hyperlipidemia, 560-569 historical perspective
Diethylstilbestrol, teratogenic effects of, over-the-counter, 37
36-37 principles for, 37
Diffusing capacity for carbon monoxide, in occupational exposure to, 1093-1094
occupational lung diseases, 1013 reproductive disorders in, 1041, 1046-
Diflorasone, in psoriasis, 398 1047
DiGeorge syndrome, heart defects in, 769 Dry skin, in atopic dermatitis, 506
Digital subtraction angiography, in hyper- Ductus arteriosus, patent, 7
tension, 598 Duplex ultrasonography
Digoxin, in atrial arrhythmias, 694, 697, 598
700 Dusts, occupational exposur
in heart failure, 664 See also Pneum
Diltiazem, in angina, 625 Dysbetalipoproteinemia, 542
in atrial arrhythmias, 695-697, 700 Dyspepsia, in pregnancy and lactation
in hypertension, 601 drugs for, 48
Dimethylmercury poisoning, 989 Dyspnea, in heart failure
Dioxins, occupational exposure to, 951-955 in mitral stenosis, 734
Diphenhydramine, in atopic dermatitis, 511
Dipyridamole, in coronary artery disease
791-792
Disability, evaluation of, for workers’ com-
Ear, external, infections of, 469-470
pensation, 841-842
Echocardiography exercise, 793
prevention of, in employment, 824
in coronary artery disease, 749
Discoid lupus erythematosus, alopecia in,
3a3 in heart failure, 659, 661, 796
in hypertension, 597
Discoloration, of nails, 336-338
n valvular disease. See specific diseases
Disinfectants, occupational exposure to,
1095 stress, 792-793
Econazole, in tinea pedis, 41
reproductive disorders in, 1041, 1047
Ecthyma gangrenosum, 470-
Disopyramide, in atrial arrhythmias, 694
Eczema. See Atopic dermatitis
Diuretics, in heart failure, 663-664
in hypertension, 600, 757 Edema, in heart failure, 658
lipid effects of, 576 in rosacea, 313-314
Dobutamine, in stress testing, in coronary Education, medical, on occupational medi-
artery disease, 791-792 cine, 826-827
Domestic violence, prenatal screening for, patient, on acne, 306-307
56-60 on occupational medicine, 822-824
Down's syndrome, prenatal screening Elastin defects, heart disease in, 769
for, 88 Elbow, work-related disorders of, 854-855
Doxycycline, in acne, 299 evaluation of, 848-849
Dressings, 490 risk factors for, 847—848
for abrasions, 479-480 treatment of, 849
for blisters, 481—482 Elderly persons, coronary artery disease
for burns, 482, 485-486 5 —578 745
Drug(s), abuse of, screening for, in pericon- hyperlipidemia in, 577-578
ception care, 4 hypertension in, 605-606
in pregnancy and lactation, 35-53 Electrical cardioversion, in atrial fibrilla-
alternative, 51-52 tion, 701-702
anesthetic agents, ° Electrical hazards, in health care, 1097
1112 CUMULATIVE INDEX 2000
Electrocardiography. See also specific Estimated date of confinement, calculation
arrhythmias and valvular diseases. of, 74
angina, 618 Estriol test, in pregnancy, 88
arrhythmias, 679, 699, 798 Estrogen, deficiency of, coronary artery dis-
cor-on—ar y artery; disease, 748-749, 790- ease in, 530-531, 575, 577, 7 45-746
in acne, 303
in hypertension, 597 replacement of, in )
in myocardial infarction, 633-634 in heart disease prevention, 645, 759-
Electrocautery, in subungual hematoma 760
drainage, 489 Ethane, occupational exposure to, 958-959
Electrodesiccation, of skin cancer, 455 Ethnic factors, in coronary artery disease
of warts, 431 526-527, 578-579, 745
Electrophysiologic studies, in cardiac ar- in hyperlipidemia, 578-579
rhythmias, 798 in hypertension, 603-605
Electrosurgery, in rhinophyma, 316-317 Ethylene glycol dinitrate, occupational
Emergency, hypertensive, 594 posure to. 936-939
Emollients, in atopic dermatitis, 511 Ethylene oxide, occupational exposure
in psoriasis, 397 931-933, 1095
Employment. See also Occupational reproductive disorders in, 1047
medicine. Exanthem subitum (roseola infantum)
during pregnancy, 108-111 356-35 6
Enalapril, in heart failure, 665 Exanthems, in pediatric patients, 353-370
Endocarditis, antibiotic prophylaxis for, in erythema infectiosum, 357-358, 367
aortic stenosis, 729-730 erythema multiforme, 364-365, 368
in mitral stenosis, 735 Gianotti-Crosti syndrome, 360-361, 368
in pregnancy and lactation, drugs for, 39 Henoch-Schonlein purpura, 363-364, 368
Endtoriccruisnpei d dirseogrudregrist,a tiion n prdeugen atnoc, y 736a nd lac- mKeanwiansgaokcio ccseymnidar,o me,3 613-5396, 2, )3 67,3 687 73—774
tation, drugs for, 49 Rocky Mountain spotted fever
368
Endometritis, postpartum, 19-21, 43 : el ate
Endothelins, as vasoconstrictors, 590 roseola infantum, 356-357, 367
rubella, 355- 356, 367
Endothelium, vasoactive substances se-
rubeola, 3 54-355, 367
creted by, 590
staphylococcal scalded skin syndrome
Environmental exposure. See also Occupa-
365-366, 368
tional medicine.
varicella, 358, 367
in risk assessment, in pregnancy, 75-76
Excision, of skin cancer, 454-455
Epicondylitis, work-related, 854-855
of warts, 431
Epidermodysplasia verruciformis, 427
Excoriation, definition of, 285
Epidermophyton infections. See Dermatophiy-
Exercise, as shiftwork countermeasure,
tosis.
1070-1071
Epilepsy, shiftwork effects on, 1067
in heart failure, 670
Ergonomic hazards, to health care workers, in hyperlipidemia, 570
1096-1097 in pregnancy, 80-81, 112
Erosion, definition of, 284 lack of, coronary artery disease in, 53
Eruptive xanthomas, in diabetes mellitus, 534. 743
380-381 types of, heart function and, 776
Erysipelas, 460-462 Exercise testing, in coronary artery disease,
Erysipeloid, 466 618, 748-749, 790-791
Erythema, in rosacea, 311 in sports participation evaluation, 713-
Erythema infectiosum, 357-358, 367 7
in pregnancy, 24, 87, 108 Exfoliation, in staphylococcal scalded skin
transmission of, to health care workers, syndrome, 365-366
1088, 1091 Expert witness, in workers’ compensation
Erythema multiforme, 364-365, 368 cases, 841
Erythrasma, in diabetes mellitus, 374-375 External otitis, 469-470
Erythrodermic psoriasis, 394 Extraction, of comedones, 305
Erythromycin, in acne, 297-299 Extrinsic allergic alveolitis, occupational,
Esmolol, in atrial arrhythmias, 694, 697 1020-1023